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antioxidants and enzymes such as glutathione peroxidase map to loci on chromosome 3p which are subject to frequent (8, 11) . Glutathione peroxidases reduce organic peroxides and loss of heterozygosity (LOH) in lung tumours. Levels of hydrogen peroxides through the coupled oxidation of reduced the pro-mutagenic, oxidative DNA lesion 8-OHdG, were glutathione (GSH). Glutathione peroxidase I (GPX1) is the measured in 37 paired normal and tumorous lung specimajor cytosolic form of this enzyme, but other isozymes are mens using HPLC with electrochemical detection. Lung found in the plasma and phospholipid membranes (12) . tumours were also analysed for 3p LOH by fluorescent
Once formed, 8-OHdG lesions are subject to DNA repair PCR with Genescan analysis. No significant difference was primarily through the base excision repair pathway (13) . A observed between 8-OHdG levels in tumour [7.7 ⍨ 6. 7 key component of this pathway is a specific DNA glycosylase/ (mean ⍨ SE) 8-OHdG/10 6 2Ј-deoxyguanosine (dG)] and apurinic (AP) lyase which catalyses the release of 8-OHdG normal (8.1 ⍨ 8.8 8-OHdG/10 6 dG) lung tissue. Adduct and the cleavage of DNA at the AP site (14) . Inactivation levels in normal lung tissue DNA were not associated with of this 8-OHdG glycosylase generates a mutator phenotype constitutive hOGG1 genotype although there was a trend characterized by GC→TA transversions in Escherichia coli towards lower 8-OHdG levels in individuals possessing the and yeast (15, 16) . Recently the human homologue of this ALA6 GPX1 polymorphism. Lung tumours exhibiting 3p gene, hOGG1 has been identified (17-19). The gene product LOH (40%) contained higher levels of 8-OHdG adducts constitutes an 8-OHdG DNA glycosylase/AP lyase which (10.9 ⍨ 2.6 8-OHdG/10 6 dG) (P ⍧ 0.05) and lower GPX1 exhibits greatest specificity and activity for 8-OHdG:dC and is enzyme activity [45.5 nmol glutathione (GSH)/min/mg] completely inactive against 8-oxodeoxyguanosine:dA (17,19). (P ⍧ 0.09) when compared with tumours without LOH at hOGG1 has also been shown to excise 2,6-diamino-4-hydroxythese sites (5.55 ⍨ 0.87 8-OHdG/10 6 dG and 63.6 nmol 5-formamidopyrimidine residues in a similar manner to its GSH/min/mg, respectively). In conclusion, tumours with yeast homologue (20) (21) (22) . 3p LOH at loci associated with hOGG1 and GPX1 appear
The level of 8-OHdG measured in a tissue at any one time to have compromised oxidative defence mechanisms as is an integration of a number of parameters including the level measured by reduced GPX1 enzyme activity and elevated of ROS, tissue redox status, cellular antioxidant defence 8-OHdG levels and this may affect the prognosis of lung mechanisms and DNA repair systems. The effectiveness of cancer patients.
these latter systems may be subject to modulation by gene polymorphisms and gene dosage effects. A number of hOGG1 polymorphisms have been described in Japanese populations, and a Ser/Cys (0.57/0.43) substitution in exon 7 is highly Introduction prevalent (23-25). Preliminary evidence from an E.coli complementation assay suggests that the hOGG1-Cys isoform Lung cancer accounts for 18% of the global cancer burden in exhibits reduced 8-OHdG repair activity (23) and may play a men and over 1 000 000 new cases of this disease were role in increasing susceptibility to squamous cell carcinoma reported in 1990 (1) . Cigarette smoke is implicated in the of the lung (25). Polymorphisms in GPX1 are characterized development of 90% of these tumours (1), through exposure by a variable polyalanine repeat and the six-alanine repeat to carcinogens such as benzo[a]pyrene, 4-(methylnitrosamino)-form (ALA6) also contains a proline→leucine substitution at 1-(3-pyridyl)-1-butanone and reactive oxygen species (ROS) codon 198 towards the C-terminus (12) . Thus, constitutive generated by compounds including catechol and hydroquinone genotype may play a significant role in determining 8-OHdG (2). At least 35 different oxidative base modifications have levels within tissue DNA. been reported when ROS react with DNA (3-7). One of the Finally, both GPX1 and hOGG1 locate to regions of chromomost common lesions formed is the pro-mutagenic DNA some 3p (3p21 and 3p25/26, respectively) which are subject to frequent and early loss of heterozygosity (LOH) during
Abbreviations: AP, apurinic; dG, 2Ј-deoxyguanosine; GPX1, glutathione lung cancer development (12, 18, 26 OHdG within dysplastic and neoplastic tissue.
from the homogenized solution using G100 columns (Qiagen Ltd, Crawley,
The aims of this study were to examine the effect of GPX1 
Materials and methods
3 µm particle size C-18 reverse phase column (Chrompack, Millharbour, UK) at 25°C using 100 mM sodium acetate buffer with 5% methanol (pH 5.2 with Tissue collection H 3 PO 4 ) at 1 ml/min. The electrochemical detector was set at oxidation Resected lobectomy and pneumonectomy specimens were collected on ice at potentials of ϩ450 and ϩ850 mV for 8-OHdG and 2Ј-deoxyguanosine (dG) surgery from untreated primary non-small cell lung cancer patients (n ϭ 37) analyses, respectively. Preceding electrodes were set at ϩ230 and ϩ800 mV, at Leeds General Infirmary (LGI). Paired tumour and uninvolved peripheral respectively, to screen out other electrochemically active compounds. dG lung tissue (designated normal), which were surplus to diagnostic requirements, eluted at 7.5 min and 8-OHdG at 11 min. 8-OHdG and dG levels were were dissected by a consultant pathologist. Specimens were cut into pieces quantitated from samples by comparing the peak areas obtained against (200-400 mg) and fixed either in formalin for histology or frozen immediately 8-OHdG (ESA Inc.) and dG (Sigma, Poole, UK) standard curves generated at -80°C for molecular and biochemical analyses. Smoking status from on the optimized electrode channels. patients was limited to self-reported information, but all patients were either During the development of this technique, an association between homogencurrent or former smokers. Most squamous cell carcinoma samples (82%) ization time and 8-OHdG level was observed in our laboratory. Specifically, collected were from male patients, as opposed to adenocarcinomas, which when homogenization times were raised from 20 to 40 and 60 s (in 10 s were predominantly (75%) obtained from female patients.
bursts), adduct levels rose by 34 and 71%, respectively. In view of this, tissue Histology homogenization times were standardized to exactly 2ϫ10 s bursts throughout this study. The coefficient of variation for replicate injections on the HPLCHistopathological diagnosis was performed by hospital pathologists according ECD ranged between 1.91 and 5.96% and for duplicate independent tissue to the WHO lung carcinoma classification. To verify that tumorous specimens extractions and analyses performed several weeks apart was 26%. Data contained Ͼ50% tumour cells and that uninvolved tissue contained Ͻ10%
presented are from the primary extraction, where there was sufficient paired contaminating tumour material, paraffin-embedded sections (5 µm) from lung normal and tumour tissue to permit parallel extractions and analyses. specimens were stained with haematoxylin and eosin and examined by light microscopy. Normal and tumorous lung tissue was microdissected where GPX1 enzyme activity appropriate from sequential tissue sections (5 µm) and genomic DNA extracted Tumour tissue samples were washed thoroughly in ice-cold buffer [0.15 M using proteinase K digestion followed by phenol/chloroform extraction as Tris-HCl (pH 7.5), 1 mM EDTA, 2 mM 2-mercaptoethanol] to remove described previously (27) .
contaminating blood, before homogenization using an Ultra-Turrax T25 Genotyping and LOH analysis (2ϫ10 s bursts at 13 500 r.p.m.). Homogenates were centrifuged initially at DNA was subject to PCR using fluorescent primers directed against the 10 000 g for 15 min at 4°C, before these supernatants were centrifuged following chromosome 3p markers: GPX1, FAM 5Ј-GAAACTGCCT-(105 000 g for 60 min at 4°C) and the resulting cytosolic fractions used for GTGCCACGTGACC-3Ј and 5Ј-CGAGAAGGCATACACCGACTGGGC-3Ј; enzyme and protein analyses. Glutathione peroxidase activity was measured hOGG1, FAM 5Ј-ACTAGTCTCACCAGCCGTGAC-3Ј and 5Ј-TGGCCTTaccording to the method of Paglia and Valentine (28) where hydrogen peroxide TGAGGTAGTCACAG-3Ј; D3S1259, FAM 5Ј-GCTGGACTATATTTGAwas used as substrate at a final concentration of 0.25 mM. The reaction mix AACTCATT-3Ј and 5Ј-TTTCAGTGAGCCAAGATCGT-3Ј; D3S1351, TET (1 ml) contained 50 mM potassium phosphate buffer (pH 7.0), 1 mM EDTA, 5Ј-ACAGAACCAGAACCAATAGG-3Ј and 5Ј-AGCCTCCATAACTGCAT-1.5 mM sodium azide, 1 mM GSH, 0.16 mM NADPH, 0.33 U/ml glutathione GAA-3Ј.
reductase and 200 µl of cytosolic fraction. After a 5 min preincubation, the Aliquots of 0.5 µl of template DNA were added to a PCR mix containing reaction was initiated by the addition of hydrogen peroxide. The rate of 0.5 U AmpliTaq Gold (Perkin-Elmer Cetus, Norwalk, CT), 10 pmol each reaction was determined at 20°C by measuring the decrease in absorbance at primer, 2.5 µl 10ϫ Taq buffer, 200 µM dNTPs, 1.5 mM MgCl 2 and water to 340 nm. Cytosolic protein concentrations were measured using the Bio-Rad a final volume of 25 µl. Cycling conditions for GPX1, D3S1259 and DS1351 protein assay (Bio-Rad, Hemel Hempstead, UK). Specific activity is given as were: 95°C for 15 min; 30 cycles of 1 min at 95°C, 1 min at 56°C, 1 min at nmol GSH oxidized/min/mg cytosolic protein. 72°C; followed by an extension step for 10 min at 72°C. The annealing Statistics temperature was modified to 50°C for the hOGG1 PCR. For every PCR experiment, water served as a negative template control.
Statistical analyses were performed using the Mann-Whitney U-test and PCR products were separated on a 6% denaturing acrylamide gel and Kruskall-Wallis non-parametric ANOVA. analysed using a 373A automated DNA sequencer with Genescan analysis (27). LOH was defined as a change in allele ratio of Ͻ0.6 between normal and matched tumour tissue DNA, which was reproduced on three independent (80%) of normal and tumour samples contained Ͻ10 8-OHdG/ Products were visualized on a 2.0% agarose gel and compared with known 10 6 dG. There were no significant differences observed in genotype standards (confirmed by direct sequencing). In addition to the lung cancer cases, leukocytes from 47 healthy individuals were sampled from the 8-OHdG levels either between normal and tumorous tissue or general population to estimate the prevalence of these polymorphisms within across different tumour types (Figure 1) . Furthermore, nodal Caucasians. involvement was not related to tumour 8-OHdG levels. In Only limited qualitative information was available on the for 8-OHdG adduct analysis, although considerable care must be exercised to smoking status of these lung cancer cases, except that all cases avoid artefactual 8-OHdG formation during sample collection and preparation. Thus, a phenol-free method with ethanol precipitation was used to extract were known to be current or former smokers. Therefore adduct tissue DNA in this study. Briefly, tissue (100 mg) from each specimen was levels could not be correlated quantitatively to smoking status. Each sample was then homogenized on ice in 9.5 ml lysis buffer using an Ultra-Turrax T25 (2ϫ10 s bursts at 8000 r.p.m.). DNA was extracted was a trend towards reduced 8-OHdG levels in the presence of the ALA6 allele this result was not statistically significant (P ϭ 0.421). Discussion We also examined the association between hOGG1 genotype and adduct level. A typical hOGG1 restriction fragment length A role for specific gene polymorphisms in relation to susceptibility to lung cancer has been highlighted for a number of polymorphism (RFLP) result is shown in Figure 3A . It was noted that the hOGG-Ser allele was more prevalent (0.76) in genes, including myeloperoxidase (29) and glutathione S-transferases (30,31). However, markers of biological effects this control Caucasian population compared with previous reports on Japanese populations (0.59) (23,25). Furthermore, on the disease pathway are rarely used to demonstrate a mechanistic link between genotype and disease. Such a link hOGG1 allele frequencies (Ser/Ser:Cys/Ser:Cys/Cys) did not vary significantly between the lung cancer cases would contribute to establishing a causal association between the two. In this study, the significance of GPX1 and hOGG1 (0.53:0.41:0.06) and the general Caucasian population (0.56:0.40:0.04) in this study, indicative that a strong hOGG1 polymorphisms in protecting against oxidative stress and potentially in the aetiopathogenesis of lung cancer was allele selection pressure was not operating in the lung cancer cases. This is consistent with the fact that levels of 8-OHdG addressed by examining their effect on levels of the promutagenic lesion 8-OHdG in lung tissue. in normal lung DNA did not vary with hOGG1 genotype (P ϭ 0.472) ( Figure 3B ).
Since guanine is the most readily oxidized DNA base, the use of 8-OHdG as a dosimeter for oxidative stress is the LOH at one or more markers on chromosome 3p was observed in 40% of lung tumours. The mean 8-OHdG level subject of debate in the light of susceptibility to artefactual formation during sample processing and measurement (32-in these tumours was double that observed in tumours which showed no evidence of LOH (P ϭ 0.05) ( Figure 4A ). Further-34). In particular, phenol, light, heat, methanol and silylation steps in GC-EIMS have all been highlighted as potential more, the GPX activity of these tumours was reduced by one third when compared with tumours exhibiting no 3p LOH sources of artefactual 8-OHdG formation. Thus, rigorous procedures were employed in our study to minimize and ( Figure 4B ), although this was not significant (P ϭ 0.09).
compared with the hOGG1-Ser isoform. In the current study, we were unable to find evidence to support a role for the hOGG1 genotype in determining 8-OHdG levels in nontumorous tissue from a series of 34 lung specimens. This suggests that differences in 8-OHdG glycosylase activity within hOGG1 polymorphic variants are insufficient to impact upon tissue 8-OHdG levels. Alternatively, it may reflect a lack of resolution regarding adduct analysis in that current methodologies are limited to measurements in total genomic DNA and cannot be targeted to specific regions, e.g. transcriptionally active sites. In addition, repair of 8-OHdG may not be wholly effected by hOGG1. Monden et al. (36) confirmed that OGG1 (type 1a isoform) constitutes the major 8-OHdG glycosylase activity detectable in human cells. However, other repair enzymes also demonstrate some 8-OHdG glycosylase activity in vitro and could contribute to the persistence of 8-OHdG within tissues (37, 38) . Perhaps of most significance, Hazra et al. (38) recently identified OGG2, which preferentially excises 8-OHdG when paired with G or A. In light of the substrate specificities outlined for OGG1 and OGG2, the effects of hOGG1 polymorphisms may be more subtle and perhaps require discrimination within a base pair context. Furthermore, chromatin structure and sequence context are likely to be important factors not only in determining the site of 8-OHdG adduct formation, but may also affect efficiency and/or progression.
In principle, one of the limitations in the type of study we describe here is that tissue specimens were collected from control for sources of experimental error, which included: (i) the transit time between surgery and sample storage was people undergoing surgery and hence with prevalent disease. Additionally, it is often a fact that there is incomplete quantitatminimized; (ii) tissue dissection was performed by a consultant pathologist in order to optimize and standardize the quality of ive data available on other environmental exposures, e.g. smoking, as in this study. Thus, both the presence of disease tissue specimens collected; (iii) all tissue was processed using a standardized laboratory protocol with carefully timed tissue and these latter factors could act as confounders of the relationship between adduct level and genotype. Therefore, for homogenizations, an additional factor which we found could lead to an increase in adduct levels (see Materials and methods). a polymorphism to cause detectable change in 8-OHdG levels, the association would have to be relatively strong. Levels of adduct which were measured in this study are consistent with those reported by Inoue et al. (35) , who Notwithstanding the caveats outlined above, a global elevation in 8-OHdG levels was observed in tumor tissue which described a mean 8-OHdG level of 5.2 8-OHdG/10 6 dG in the peripheral lung of lung cancer cases compared with 8.1 exhibited LOH within GPX1 or at loci close to hOGG1. This appears to indicate that oxidative defences are indeed 8-OHdG/10 6 dG in the current study. There was somewhat more inter-individual variability observed in the present study, compromised in lung tumours which exhibit 3p LOH at these sites and is further supported by the finding that GPX1 enzyme but 80% of samples fell within the range (i.e. Ͻ10 adducts/ 10 6 dG) reported by Inoue et al. (35) . Neither study found a activity was reduced in these tumours. To date, most studies on the lung have compared GPX1 activities across normal and difference in 8-OHdG levels between non-tumorous lung tissue from adenocarcinoma and squamous cell carcinoma patients.
tumorous tissue with somewhat inconclusive results (39, 40) . That GPX1 activity is reduced in some but not all tumours These findings also concur with an earlier study (2) on the central lung, where 8-OHdG levels did not differ between relative to normal tissue may in part reflect 3p LOH events in these tumours. In the current study, reduced GPX1 enzyme normal and tumorous tissue nor across different lung tumour types.
activity does not appear to completely account for the elevated 8-OHdG levels observed in tumours with 3p LOH, because Preliminary findings presented here indicate a trend towards lower 8-OHdG levels in normal lung tissue possessing the the correlation between GPX1 enzyme activity and 8-OHdG levels in tumours at the individual level was poor (data not ALA6 allele of the GPX1 gene, implying a possible functional change in enzyme activity as a result of sequence charactershown). Future studies will address whether hOGG1 activity is also compromised in tumours exhibiting 3p LOH, although istics. However, further studies are required to define the role of this polymorphism in relation to the function of GPX1 and the involvement of other genes which locate to these regions of chromosome 3p cannot be precluded. its role in protection against oxidative DNA damage.
The hOGG1-Ser and -Cys polymorphisms were initially In conclusion, preliminary results indicate that endogenous 8-OHdG levels in the lung may be lower in individuals identified by Kohno et al. (23) . Based upon in vitro evidence utilizing an E.coli complementation assay, the hOGG1-Cys possessing the GPX1 ALA6 polymorphism but are not affected by the hOGG1 genotypes examined. 3p LOH at chromosomal allele appeared to exhibit a poorer 8-OHdG repair activity 17. Abarutani,H., Hippo,Y., Ishida,T., Takashima,R., Matsuba,C., Kodama,T., sites associated with lung cancer development appear to Takao,M., Yasui,A., Yamamoto,K., Asano,M., Fukasawa,K., Yoshinari,T., compromise antioxidant defences, including GPX1 enzyme 
